An Electronic Pillbox for People With HIV
A Novel Technology to Improve HIV Medication Compliance
1 other identifier
interventional
75
1 country
1
Brief Summary
Anti-HIV drug regimens can be very complicated. This study will evaluate a new electronic pillbox designed to help people take their anti-HIV drugs correctly.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1 hiv-infections
Started Oct 2003
Longer than P75 for phase_1 hiv-infections
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2003
CompletedFirst Submitted
Initial submission to the registry
October 24, 2003
CompletedFirst Posted
Study publicly available on registry
October 28, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2009
CompletedSeptember 26, 2008
September 1, 2008
3.7 years
October 24, 2003
September 25, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Medsignals performance
Throughout study
Study Arms (3)
1
EXPERIMENTALParticipants will use MedSignals with all of its features
2
EXPERIMENTALParticipants will use MedSignals with only alarm features
3
NO INTERVENTIONParticipants will not use any device
Interventions
An electronic device that is used to improve medication compliance among HIV patients. It allows convenient storage and transport of antiretroviral medications and functions as an aid to compliance by incorporating reminding alarms at dosing times and usage reporting functions.
Eligibility Criteria
You may qualify if:
- HIV-infected for at least six months prior to study entry
- Currently taking at least one and not more than four antiretroviral medications (not including medications for prophylaxis or unrelated disorders)
- Understand the benefits of antiviral medications in reducing viral load, boosting immune response, and preventing opportunistic infections
- Desire to take all antiretroviral medication as scheduled
- Working telephone
- Ambulatory
- Good mental health
You may not qualify if:
- Require assistance dispensing or taking medications
- Require full or part time assistance with the activities of daily living
- Does not intend to take all anti-HIV medication over the course of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
LIFETECHniques, Inc.
Santa Barbara, California, 93101, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vesta Brue, MBA
Chairman
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- NIH
Study Record Dates
First Submitted
October 24, 2003
First Posted
October 28, 2003
Study Start
October 1, 2003
Primary Completion
June 1, 2007
Study Completion
June 1, 2009
Last Updated
September 26, 2008
Record last verified: 2008-09